Overview
Cardiovascular disease risk refers to the probability that an individual will develop disorders of the heart and blood vessels, estimated from modifiable and non-modifiable risk factors and quantified using risk-scoring tools. Major contributors include hypertension, dyslipidemia, diabetes, obesity, smoking, physical inactivity, age, sex, and genetic predisposition. Risk assessment guides preventive strategies, from lifestyle modification and blood-pressure control to lipid management, and tools such as the Framingham risk score are used to stratify individuals and inform intervention intensity. Research in this area addresses the measurement, determinants, and modulation of cardiovascular risk. Studies examine racial and ethnic differences in Framingham risk scoring, hypertension management and the efficacy and safety of antihypertensive combinations, and bioinformatic analysis of coronary-disease-associated genetic variants implicated in atherosclerosis. Additional work covers cardiovascular risk factors in relation to depressive symptoms in vulnerable diabetic patients, blood-pressure responses during resistance exercise, microRNAs as tools in hypertension, metabolic acidosis and cardiovascular disease in dialysis patients, and risk-factor trajectories in congenital heart disease. Studies on optimal timing of obstetric events in hypertensive women further connect reproductive and cardiovascular risk. This peer-reviewed literature supports clinicians and researchers focused on risk stratification, prevention, and the management of factors driving cardiovascular disease.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Cardiorenal Signaling Pathways in Heart Failure: Good and Bad News
Late Age at Menarche Increased Common Carotid Artery Intima-Media Thickness in Overweight and Obese Women
Efficacy and Safety of Lercanidipine Combination in Hypertensive Patients
Rate Pressure Product Responses during an Acute Session of Isometric Resistance Training: A Randomized Trial
MicroRNAs: As A Novel Potential Tool for Diagnosis, Prognosis, and Therapeutic Agents in Hypertension.
Racial/Ethnic Differences in Framingham Risk Score in an NHANES Cohort
Stemming The Tide Of Hypertension In Women: Optimal Age For Obstetric Debut
Bioinformatic Analysis of Coronary Disease Associated SNPs and Genes to Identify Proteins Potentially Involved in the Pathogenesis of Atherosclerosis
Metabolic Acidosis and Cardiovascular Disease in Patients on Peritoneal Dialysis
Single Daily Activity or Exercise Capacity Measurements Did not Predict Future Changes in Cardiovascular Risk Factors in Congenital Heart Disease
Cardiac Mechanics in Patients with Systemic Hypertension with Normal EF: A Speckle - Strain Imaging Study
How this research is being cited
The 12 articles above have been cited 70 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2025 · Bulletin of Faculty of Physical Therapy
-
2025 · European Journal of Applied Physiology
-
2025 · Translational Journal of the American College of Sports Medicine
-
2025 · Computational and Structural Biotechnology Journal
-
2025 · Journal of Molecular Structure
-
2025 · Bulletin of Faculty of Physical Therapy
-
2025 · Translational Journal of the American College of Sports Medicine
-
B. H. Wright et al. · 2025 · European Journal of Applied Physiology
A sample of recent works citing this journal's research on Cardiovascular Disease Risk, linking to each citing work.